
Retatrutide
Unapproved · Not compoundableInvestigational triple agonist at the GIP, GLP-1 and glucagon receptors. Approved nowhere; supplied on enquiry only.
- Format
- 10 mg lyophilised
- Purity
- ≥ 99% (HPLC)
- Note
- Unapproved investigational agent
Every fill is batch-coded and tied to a certificate of analysis you can request by lot number — identity and purity for the vial in front of you, not a representative run.
Orders go against a stated research use. Not to individuals, and not to clinics sourcing material for patients.

Investigational triple agonist at the GIP, GLP-1 and glucagon receptors. Approved nowhere; supplied on enquiry only.

Pentadecapeptide matching a fragment of a protein found in gastric juice.

Synthetic fragment corresponding to the actin-binding region of thymosin β4.

Two-component blend: the pentadecapeptide BPC-157 alongside TB-500.

Two-component blend pairing the GRF(1–29) analogue with the pentapeptide ipamorelin.

Forty-four residue analogue of growth hormone-releasing hormone, acylated at the N-terminus.

Sixteen residues, encoded in the mitochondrial genome rather than the nuclear one.
Order of residues is what a peptide is. Pick a compound and its chain builds, coloured by the biochemical class of each residue — the same key used on the fingerprint under every product above.
Two things moved this year and most of our category has not updated its copy. Removal from Category 2 is not permission to compound, and an advisory vote is not a rule. Both matter if you are planning around availability.
| Compound | April 2026 | July 2026 — PCAC | Compoundable today |
|---|---|---|---|
| Retatrutide | Not applicable | Not applicable | No — unapproved drug |
| BPC-157 | Off Category 2 | Recommended, 8–6–1 | No — rulemaking pending |
| TB-500 | Category 2 | Not reviewed | No — Category 2 |
| BPC-157 / TB-500 | BPC-157 off Category 2; TB-500 in Category 2 | BPC-157 recommended, 8–6–1 | No — TB-500 in Category 2 |
| CJC-1295 + Ipamorelin | CJC-1295 in Category 2; ipamorelin off Category 2 | Not reviewed | No — CJC-1295 in Category 2 |
| Tesamorelin | Not in this group | Not reviewed | Approved form exists — EGRIFTA |
| MOTS-c | Off Category 2 | Recommended, 7–5–2 | No — rulemaking pending |
Requested, not enclosed. Certificates are not shipped with the vial — ask for one by lot number, before or after purchase, and we issue it for that lot. Identity, purity by HPLC and the analytical detail your records need, tied to the lot in front of you rather than a representative run.
Printed at fill, so any vial traces back to its production run. If a lot is ever withdrawn you can tell in seconds whether you hold it.
Lyophilised, shipped ambient, with reconstitution and storage guidance for laboratory conditions. Cold chain available on request for longer transit.
Orders are accepted from institutions and research organisations against a stated research use. Enquiries are screened before anything is quoted — institutional email, organisation type and a stated use are all conditions of supply. Once you clear, we confirm availability, lot and lead time, and send the certificate of analysis for the lot you are quoted.